Navigation Links
'Alliance for Medical Devices, Instrumentation and Diagnostics' formed between Fraunhofer Center for Manufacturing Innovation and Boston University

PLYMOUTH, Mich., Sept. 10 /PRNewswire/ -- The primary objective of the Alliance is to improve patient care by accelerating the delivery of biomedical advances to the marketplace.

To celebrate the Alliance, a symposium was held at Boston University on Friday, September 7th with noted speakers from industry, government, entrepreneurs, venture capitalists and the Presidents of both Boston University and Fraunhofer Gesellschaft.

The alliance will take advantage of the two institutions' respective strengths. Advanced biomedical research is being conducted throughout BU's College of Engineering, College of Arts and Sciences, and Medical School, resulting in many potential medical innovations. Fraunhofer hopes to take these innovations and convert them into working medical devices and instruments that can be licensed to existing companies or created by new, spin-off ventures. The Alliance will leverage the most promising research innovations in labs through Boston University, particularly in its College of Engineering, with the goal of making a significant impact on the way clinical medicine is practiced.

Fraunhofer Gesellschaft is very active in biomedical research. Current activities include plant-based vaccine development, medical imaging, array- based diagnostics, surgical micro-tools development, and other novel devices and instrumentation.

The Fraunhofer Center for Manufacturing Innovation was established at Boston University in 1995. Working with BU faculty, students and international interns, the engineers at the Center scale-up basic research into advanced technologies that meet the needs of client companies both locally and globally. The focus of the Center is on the development of next-generation instruments and high precision automation systems for the biotech/biomedical, photonics, and semiconductor industries.

Boston University Professor Andre Sharon, who is also Executive Director of the Fraunhofer Center for Manufacturing Innovation stated, "The alliance will leverage the most promising research innovations in labs throughout Boston University, particularly in its College of Engineering."

BU College of Engineering Dean Kenneth R. Lutchen stated "This initiative will further accelerate our most promising research in this area so improved medical care can be delivered to patients as soon as possible."

To learn more about Fraunhofer USA, Inc., please visit

Fraunhofer USA, Inc. is a non-profit research and development corporation, with headquarters in Michigan. It operates through technology centers that are partnered with major research universities in the United States and also with parent research institutes in Germany.

Contact: Frances Roland-Lee


SOURCE Fraunhofer USA
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Biomedical Alliance about more than stem cells
2. Doyle seeks $2.5M for biomedical alliance
3. Alliance looks to create the right chemistry in SE Wisconsin
4. Biomedical alliance marks first full year
5. New alliance to provide Wi-Fi network for City of Madison
6. Budget axe could cut SE Wisconsin tech alliance funding
7. Biotech Alliance pushes ahead in SE Wisconsin with likely state funding
8. Milwaukee research alliance sees need for incubator
9. University alliance gets $2.5 million to encourage minorities in science and technology
10. Suite Scheduler Announces Alliance with Ice Technologies
11. Alliance Brings E-Business Technologies to Wisconsin Manufacturers
Post Your Comments:
(Date:6/23/2016)... ... June 23, 2016 , ... ... launch of the Supplyframe Design Lab . Located in Pasadena, Calif., the ... future of how hardware projects are designed, built and brought to market. , ...
(Date:6/23/2016)... ... 2016 , ... In a new case report published today in STEM CELLS ... developed lymphedema after being treated for breast cancer benefitted from an injection of stem ... with this debilitating, frequent side effect of cancer treatment. , Lymphedema refers ...
(Date:6/23/2016)... , June 23, 2016  Blueprint Bio, a ... discoveries to the medical community, has closed its Series ... Matthew Nunez . "We have received a ... the capital we need to meet our current goals," ... provide us the runway to complete validation on the ...
(Date:6/23/2016)... , June 23, 2016 On ... session at 4,833.32, down 0.22%; the Dow Jones Industrial Average ... 500 closed at 2,085.45, down 0.17%. has initiated coverage ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ), Aralez ... Inc. (NASDAQ: BIND ). Learn more about these ...
Breaking Biology Technology:
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC ... today announced the opening of an IoT Center of ... strengthen and expand the development of embedded iris biometric ... unprecedented level of convenience and security with unmatched biometric ... one,s identity aside from DNA. EyeLock,s platform uses video ...
(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
(Date:4/28/2016)... , April 28, 2016 Infosys ... (NYSE: INFY ), and Samsung SDS, a global ... that will provide end customers with a more secure, fast ...      (Logo: ) , ... but it also plays a fundamental part in enabling and ...
Breaking Biology News(10 mins):